These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 24482222

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice.
    Lee CK, Son SH, Park KK, Park JH, Lim SS, Kim SH, Chung WY.
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):48-54. PubMed ID: 18484961
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT, Fels LM, Franzke A, Knop S, Renn M, Maess B, Panagiotou P, Lampe H, Kanz L, Stolte H, Bokemeyer C.
    Anticancer Res; 2000 Jul; 20(5C):3767-73. PubMed ID: 11268452
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy.
    Fall N, Bove KE, Stringer K, Lovell DJ, Brunner HI, Weiss J, Higgins GC, Bowyer SL, Graham TB, Thornton S, Grom AA.
    Arthritis Rheum; 2005 Oct; 52(10):3175-80. PubMed ID: 16200621
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Carnosic acid attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
    Sahu BD, Rentam KK, Putcha UK, Kuncha M, Vegi GM, Sistla R.
    Food Chem Toxicol; 2011 Dec; 49(12):3090-7. PubMed ID: 21930180
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Metronomic low-dose chemotherapy boosts CD95-dependent antiangiogenic effect of the thrombospondin peptide ABT-510: a complementation antiangiogenic strategy.
    Yap R, Veliceasa D, Emmenegger U, Kerbel RS, McKay LM, Henkin J, Volpert OV.
    Clin Cancer Res; 2005 Sep 15; 11(18):6678-85. PubMed ID: 16166447
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
    Ye S, Yang W, Wang Y, Ou W, Ma Q, Yu C, Ren J, Zhong G, Shi H, Yuan Z, Su X, Zhu W.
    Int J Mol Med; 2013 Jan 15; 31(1):33-42. PubMed ID: 23128378
    [Abstract] [Full Text] [Related]

  • 36. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF, Macias RI, Izco-Basurko I, de La Fuente A, Pascual MJ, Criado JM, Monte MJ, Yajeya J, Marin JJ.
    J Pharmacol Exp Ther; 2001 Jun 15; 297(3):1106-12. PubMed ID: 11356935
    [Abstract] [Full Text] [Related]

  • 37. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
    Li G, Dong S, Qu J, Sun Z, Huang Z, Ye L, Liang H, Ai X, Zhang W, Chen X.
    Liver Int; 2010 Apr 15; 30(4):585-92. PubMed ID: 19780956
    [Abstract] [Full Text] [Related]

  • 38. Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: laboratory and clinical aspects.
    Capizzi RL.
    Semin Oncol; 1999 Apr 15; 26(2 Suppl 7):72-81. PubMed ID: 10348264
    [Abstract] [Full Text] [Related]

  • 39. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
    Donnelly ET, Kelley M, Rockwell S.
    Cancer Chemother Pharmacol; 2004 Jan 15; 53(1):43-50. PubMed ID: 14574460
    [Abstract] [Full Text] [Related]

  • 40. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD, Weaver RJ, Stewart KN, Brown P, Hawksworth GM.
    Toxicology; 2008 Jul 30; 249(2-3):184-93. PubMed ID: 18583013
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.